Novartis Consumer Health · Recalled
Triaminic and Theraflu Products Recalled Due to Failure to Meet Child-Resistant Closure Requirement; Risk of Poisoning
These child-resistant caps can fail to function properly and enable the cap to be removed by a child with the tamper-evident seal in place, posing a risk of unintentional ingestion and poisoning. These products contain acetaminophen and diphenhydramine which are required by the Poison Prevention Packaging Act to be sealed with child-resistant packaging.
- Units
- About 2.3 Million
- Reports
- 12
- Injuries
- —
- Deaths
- —
- Price
- $5
- Remedy
- Refund
Reports, injuries, deaths and price are read out of the notice’s wording by rules, so they can miss unusual phrasing. The official notice is the record.
Affected
This recall involves Triaminic® Syrups and Theraflu Warming Relief® Syrups for coughs, colds and fevers. There are 24 types of these two products included in the recall. A complete list of products, lot numbers and National Drug Codes (NDC) can be found at www.novartisOTC.com. Lot numbers are located on the bottom panel of the box and on the left side of the label on the bottle. The NDC number is located on the upper right corner of the front panel of the Triaminic Syrups box and the upper left corner of the Theraflu Warming Relief Syrups bottle.
The file
- Sold at
- Food, drug, mass merchandise and club stores nationwide between May 2010 and December 2011 for about $5.
- Product type
- Other Drugs or Medications
- Made in
- United States
- Recalled by
- Novartis Consumer Health Inc., of Parsippany, NJ
Incident log
The firm has received 12 reports of children unscrewing the locked caps, including four reports of children ingesting the product. One child required medical attention.
What the notice says to do
Consumers should immediately stop using the recalled product and contact Novartis for instructions on how to return the product for a full refund.
Novartis Consumer Healthcare toll-free at (866) 553-6742 from 8 a.m. to midnight ET, Monday through Saturday, or online at www.novartisOTC.com for more information.
Recall notice published by the U.S. Consumer Product Safety Commission. This site is independent: always confirm on the official notice before acting.
Notice first dated JAN 31 2013; last revised JAN 20 2015.